CHU Group Hospitalier Pitié-Salpêtrière, Service d'oncologie Médicale

Paris 5013

0 studies enrolling now · 1 studies all time

What they study most

Early Stage HER2+ Breast Cancer

Studies at this site

• An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide — Completed